Inside Providence plan 340B rebate disruption details the system’s financial and operational readiness for the new federal rebate pilot program.
AgeOptions, the Area Agency on Aging for suburban Cook County, and Pathlights offer help navigating Medicare open enrollment ...
Merck tops Q3 earnings and revenue estimates on strong oncology, new drugs and animal health sales, while narrowing its 2025 ...
Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...
Verywell Health on MSN
More Price Cuts Are Coming for Diabetes Drugs. Here's What to Expect in 2026
Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...
India Today on MSN
Shot in the arm for Indian drugmakers as US FDA moves to ease biosimilar approvals
A proposed move by the US Food and Drug Administration (FDA) to accelerate development and ease approval of biosimilars could ...
Merck shares dipped after strong earnings and higher profit guidance, as the company narrowed its 2025 sales forecast amid ...
Verywell Health on MSN
5 Medications That May Interact With Omega-3 Supplements
Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.
Investor's Business Daily on MSN
Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain
Dow Jones stock Merck topped third-quarter forecasts on Thursday, but shares skidded as its challenges with vaccine Gardasil continued.
Merck & Co Inc (MRK) reports a 4% revenue increase driven by Keytruda's demand, while facing headwinds in Gardasil sales and competitive pressures.
Capitol Notebook: Iowa AG urges federal probe into refinery exemptions under renewable fuels program
Iowa Attorney General Brenna Bird is calling for a federal investigation into refineries she says may be exploiting renewable fuel exemptions, while thousands of Iowa seniors are being urged to review ...
The News Leader on MSN
Drug manufacturer Merck announces $3B expansion at Elkton site. How many jobs are coming?
It's the latest in a string of announcements by pharmaceutical manufacturers to build or expand operations in Virginia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results